Skip to content
AI IntelligenceMar 24, 2026Primary Market
Article

NanoZymeX · €160K · Grant/Seed

Biotech startup NanoZymeX has obtained €160,000 from Venture Kick to advance a new platform for enzyme replacement therapy using lipid nanoparticles for rare diseases. The company is spun out of research.

Data Cube AI EditorialSource: Tech.eu
01

Source Brief

Biotech startup NanoZymeX has obtained €160,000 from Venture Kick to advance a new platform for enzyme replacement therapy using lipid nanoparticles for rare diseases. The company is spun out of research.